 - link Copy Url
- [  Share on twitter ](https://twitter.com/intent/tweet?text=Clinical Trials Integral to Providing More Treatment Options for Platinum-Resistant Ovarian Cancer (PROC) https://www.3blmedia.com/markdownify/node/1213591?absolute=1&via=3blnews "link to 3 B L Media's Twitter")
- [  Share on linkedin ](https://www.linkedin.com/shareArticle?mini=true&url=https://www.3blmedia.com/markdownify/node/1213591?absolute=1 "link to 3 B L Media's Linkedin")
- [  Share on facebook ](https://www.facebook.com/sharer/sharer.php?u=https://www.3blmedia.com/markdownify/node/1213591?absolute=1 "link to 3 B L Media's Facebook")
- [ email Share via email ](mailto:?subject=Clinical Trials Integral to Providing More Treatment Options for Platinum-Resistant Ovarian Cancer (PROC)&body=ESG News from Alkermes https://www.3blmedia.com/markdownify/node/1213591?absolute=1 "Share via email")
 
 

 [Health &amp; Healthcare](/CSR-News/health-healthcare)

 # Clinical Trials Integral to Providing More Treatment Options for Platinum-Resistant Ovarian Cancer (PROC)

 


 

 Apr 26, 2023 1:00 PM ET

  Campaign:  [Alkermes Medicines &amp; Focus: Cancer](/news/campaign/alkermes-medicines-focus-cancer)  ![Illustration of a medical professional talking to a patient who is sat on a chair ](/sites/default/files/2023-04/PROC%20clinial%20trails_Alkermes_041723.png)

 ▶ 

Video 

  

 

 



 

 

Patients diagnosed with platinum-resistant Ovarian Cancer (PROC) often face poor prognosis due to the limited treatment options. Watch this video to learn more about PROC and why clinical trials are critical for researching potential options.



 

 

 

 

 

 

 

 [![Alkermes logo](/sites/default/files/Clients/alks_logo.png)](/profiles/alkermes)

 



 

### More from Alkermes

###### [Equal Opportunity and Respect: Diversity, Inclusion and Belonging at Alkermes](/news/equal-opportunity-and-respect-diversity-inclusion-and-belonging-alkermes)

 Dec 27, 2023 11:25 AM ET

  



###### [Corporate Governance at Alkermes](/news/corporate-governance-alkermes)

 Dec 20, 2023 12:00 PM ET

  



###### [Alkermes’ Commitment to Integrity and Compliance](/news/alkermes-commitment-integrity-and-compliance)

 Dec 18, 2023 1:30 PM ET

  



###### [Alkermes’ Culture of Employee Engagement and Wellness](/news/alkermes-culture-employee-engagement-and-wellness)

 Dec 14, 2023 10:40 AM ET

  



###### [Patient Advocacy and Community Engagement at Alkermes](/news/patient-advocacy-and-community-engagement-alkermes)

 Dec 11, 2023 2:20 PM ET

  



###### [Pharmaceuticals in the Environment](/news/pharmaceuticals-environment)

 Nov 29, 2023 3:00 PM ET

  



###### [Environmental Protection &amp; Sustainability at Alkermes](/news/environmental-protection-sustainability-alkermes)

 Nov 21, 2023 11:30 AM ET

  



###### [Alkermes Celebrates #Movember for Men’s Health Awareness Month](/news/alkermes-celebrates-movember-mens-health-awareness-month)

 Nov 20, 2023 1:30 PM ET